The WHO warns of global shortages in diagnosis and prevention of antimicrobial resistance

The WHO warns of serious global shortages in diagnosis, prevention and financing in the face of the growing resistance to antimicrobials.

Add DEMÓCRATA to Google

Ask FREN

Published

2 minutes

Most read

Elecciones 29N · Encuestas

La media de las encuestas

Media a 16 de noviembre de 2026 · 17 institutos

  • PP31,5 %
  • PSOE27,2 %
  • Vox18,9 %
  • Frente Amplio6,4 %
  • ERC2,5 %
01020304050ene 2024jul 2024ene 2025jul 2025ene 2026jul 2026

Media del último estudio de cada instituto en 30 días y su evolución semanal desde el 23J. Partidos con al menos un 2 %.

Todas las encuestas

Elecciones generales del 29 de noviembre · Demócrata

The World Health Organization (WHO) has warned that significant gaps persist in diagnostic capacity and in prevention measures against antimicrobial resistance in numerous countries, despite the progress made in developing national plans to address this problem.

The organization pointed this out on the run-up to World Antimicrobial Resistance Awareness Week, which will take place from 18 to 24 November under the slogan "One Health, one action: Prevent AMR now." In this context, the WHO has stressed that the loss of effectiveness of drugs against resistant bacteria makes it harder to tackle common infections.

To illustrate the "growing threat" posed by antimicrobial resistance, the WHO indicates that in 2023, approximately one in every six confirmed laboratory-detected bacterial infections worldwide involved antibiotic resistance.

The UN health agency highlights that 173 countries have reported having national strategies to combat AMR, more than double the 79 that said they had these plans in 2017. However, only 22 per cent say they have secured the funding and full implementation of these strategies, according to the latest National Self-Assessment Survey on Antimicrobial Resistance Follow-up, completed by 186 countries in 2026.

"National plans are essential to protect the medicines that protect us, and the fact that most countries already have them is excellent news," WHO Director-General Tedros Adhanom Ghebreyesus said, adding that "a plan not carried out benefits no one."

There are not enough reference laboratories and surveillance systems

At the same time, the data show that most States lack laboratories with the capacity to analyze bacteria and fungi and carry out resistance testing. Only 36 per cent of countries report having a national reference laboratory with the necessary equipment to carry out this task—an outcome far from the 80 per cent target set for 2030.

The WHO warns that the lack of adequate access to diagnostic tests increases the likelihood that ineffective or unnecessary antibiotics will be prescribed, and highlights that there are also important gaps in the areas of treatment and surveillance.

In fact, only 63 percent of countries say they have guidelines on the appropriate use of antimicrobials, and just over half report having surveillance systems to monitor national antibiotic consumption and track the evolution of resistance levels to antimicrobials.

"We call on all countries to implement their plans with investments in infection prevention, surveillance, equitable access to essential antimicrobials, and quality diagnostics. Every infection prevented means fewer antimicrobials are needed, and tests ensure that patients receive the right treatment only when it is necessary," Adhanom has emphasized.

With the aim of supporting countries in addressing these weaknesses, the WHO has presented two new operational tools under the framework of the Antimicrobial Resistance Diagnostics Initiative. These tools include a prioritized catalogue of diagnostic tests and step-by-step guidance to help clinical laboratories diagnose bacterial and fungal infections.